Dr. Steffen Czich (Heilbad Heiligenstadt, DE), Dr. Gerhard Hildebrand (Heilbad Heiligenstadt, DE), Prof. Dr. Klaus Liefeith (Heilbad Heiligenstadt, DE), Thomas Wloka (Heilbad Heiligenstadt, DE), Jürgen Rost (Heilbad Heiligenstadt, DE), Holger Rothe (Heilbad Heiligenstadt, DE)
Abstract text (incl. figure legends and references)
Introduction
Regeneration and healing of cartilage defects is naturally a difficult task and even for the human body itself hard to achieve.
ObjectiveWe aimed to develop biphasic polymer-based scaffold structures for the optimal treatment of bone-cartilage defects as well as to create and synthesize a suitable material, which is biocompatible, biodegradable, and can be processed via laser-based 3D printing.
Materials and MethodsA protocol for the synthesis of ACM1 was developed, which serves as a substitute for the well-known reference system LCM2, as the latter leads to acidic degradation products in tissue and corresponding inflammatory reactions. Both materials are presented in figure 1 and were succesfully 3D-printed via 2-photon polymerization. The 2PP technique, as a variable 3D printing technique from the nm- to the cm-scale, in combination with an automated manufacturing process, represents the key to the targeted microstructuring of a 3D scaffold construct with optimal adjustment of the material stiffness and the bioactivity of the selected polymers.
Fig. 1: Chemical structures of ACM and LCM.
ResultsBased on the physiological conditions of bone/cartilage tissue, an osteochondral implant with suitable tissue-analogue cartilage- and bone-specific geometric, biomechanical and biochemical properties was designed and succesfully 3D-printed via 2-photon polymerization.
Fig. 2: Design of the newly created biphasic scaffold.
ConclusionThe achieved biphasic 3D-implant represents an excellent solution to simulate the chondrogenic and osteogenic extracellular matrix (ECM) and allows the adjustment of a defined degradation rate.
AcknowledgementThe results are content of the project "Poly-IMPLANT-Druck" (funding code: 13XP5089A-F) funded by BMBF. We thank BMBF very much for the financial support.
1N. Hauptmann et al., Int. J. Mol. Sci. 2022, 23(6), 3115
2N. Hauptmann et al., Tiss. Eng. Part B: Reviews, 2019, 25(3), 167-186